Strawberry Tongue: Causes, Evaluation, and Treatment
Strawberry tongue is most commonly associated with Kawasaki disease (KD) and scarlet fever, and when present with fever ≥5 days plus other mucocutaneous findings, you should diagnose and treat for Kawasaki disease immediately with IVIG and aspirin to prevent coronary artery complications. 1
Primary Differential Diagnosis
The key conditions to consider when evaluating strawberry tongue include:
- Kawasaki Disease - Most critical to identify due to risk of coronary artery aneurysms in up to 20% of untreated cases 1
- Scarlet Fever (Group A Streptococcal infection) - Classic toxin-mediated presentation 2
- Toxic Shock Syndrome - TSST-1-mediated exanthematous disease 2
- Epstein-Barr Virus - Emerging recognition as a cause, though less common 3
Algorithmic Approach to Evaluation
Step 1: Assess for Kawasaki Disease FIRST
Look for the diagnostic criteria 1:
- Fever for ≥5 days (though diagnosis can be made with 4 days if ≥4 principal features present, or rarely 3 days by experienced clinicians)
- Count the principal clinical features (need ≥4 of 5):
- Erythema and cracking of lips, strawberry tongue, and/or erythema of oral/pharyngeal mucosa
- Bilateral bulbar conjunctival injection without exudate
- Rash (maculopapular, diffuse erythroderma, or erythema multiforme-like)
- Erythema and edema of hands/feet (acute) or periungual desquamation (subacute)
- Cervical lymphadenopathy (≥1.5 cm, usually unilateral)
Critical pitfall: These features appear sequentially and may not all be present simultaneously. A careful history may reveal features that have already resolved 1.
Step 2: Laboratory Evaluation
Order the following tests:
- CBC with differential - Look for leukocytosis with neutrophil predominance, thrombocytosis (in second week)
- Acute phase reactants - Elevated CRP and ESR
- Comprehensive metabolic panel - Low sodium, low albumin, elevated liver enzymes
- Urinalysis - Sterile pyuria
- Rapid strep test and throat culture - To evaluate for scarlet fever
- EBV serology - If typical features of KD and strep are absent 3
- Echocardiogram - Essential if KD suspected to assess for coronary artery abnormalities 1
Step 3: Exclude Mimics
Key distinguishing features 1:
- Exudative conjunctivitis → NOT Kawasaki disease
- Exudative pharyngitis → NOT Kawasaki disease
- Oral ulcerations → NOT Kawasaki disease
- Splenomegaly → Consider other diagnoses
- Vesiculobullous lesions → Consider other diagnoses
Treatment Algorithm
If Kawasaki Disease Diagnosed:
Initiate treatment within the first 10 days of illness 1, 4:
- IVIG - Single high-dose infusion
- Aspirin - High-dose initially, then low-dose for antiplatelet effect
- Expected response: Fever should resolve within 36 hours of completing IVIG; if not, patient has IVIG resistance requiring additional therapy 1
This treatment prevents coronary artery aneurysms and must not be delayed 4.
If Scarlet Fever:
- Treat with appropriate antibiotics for Group A Streptococcus
- Penicillin or amoxicillin as first-line agents
If EBV Infection:
- Supportive care only - The condition is self-limited and resolves spontaneously within approximately 10 days 3
- No specific antiviral treatment indicated
Critical Clinical Pearls
Kawasaki disease can recur, even into adulthood, and responds well to repeat IVIG therapy 5. Consider this in patients with prior KD history presenting with compatible symptoms.
Cervical lymphadenopathy in KD may be the most prominent initial finding, mimicking bacterial lymphadenitis and significantly delaying diagnosis. Key differences: KD shows multiple enlarged nodes with retropharyngeal edema, while bacterial lymphadenitis typically presents with a single node with hypoechoic core 1.
Fever characteristics: In KD, fever is typically high-spiking (>39-40°C) and remittent. Spontaneous resolution after 7 days does NOT exclude KD diagnosis 1.
The most important clinical decision point is recognizing Kawasaki disease early, as this is the only strawberry tongue etiology with significant morbidity and mortality risk that requires urgent specific treatment to prevent permanent cardiac complications.